Dr n. o zdr. Sara Jarmakiewicz-Czaja

Publikacje

• [współaut.] Musz P, Ryś G, Fic W [et al.] Nutrigenomics and Epigenetics in the Dietary Management of Inflammatory Bowel Diseases. - Genes, 2025, Vol. 16, iss. 11
• [współaut.] Sokal-Dembowska A, Ergan K Role of gut microbiota in the development of metabolic dysfunction-associated steatotic liver disease in inflammatory bowel disease. - World Journal of Gastroenterology, 2025, Vol. 31, iss. 40
• [współaut.] Sokal-Dembowska A, Filip R Effects of Selected Food Additives on the Gut Microbiome and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). - Medicina-Lithuania, 2025, Vol. 61, iss. 2
• [współaut.] Sokal-Dembowska A, Helma K, Filip R The Role of microRNAs in Inflammatory Bowel Disease. - International Journal of Molecular Sciences, 2025, Vol. 26, iss. 10
• [współaut.] Sokal-Dembowska A, Polak-Szczybyło E, Helma K [et al.] Physical Activity and Metabolic Disorders -What Does Gut Microbiota Have to Do with It?. - Current Issues in Molecular Biology, 2025, Vol. 47, no. 8
• [współaut.] Sokal-Dembowska A, Tabarkiewicz J, Filip R Nitrate and Nitrite in the Diet : Protective and Harmful Effects in Health and Disease. - Current Nutrition Reports, 2025, Vol. 14, iss. 1
• [współaut.] Ferenc K, Filip R What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?. - Life, 2024, Vol. 14, iss. 1
• [współaut.] Ferenc K, Sokal-Dembowska A, Filip R Nutritional Support : The Use of Antioxidants in Inflammatory Bowel Disease. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 8
• [współaut.] Ferenc K, Sokal-Dembowska A, Helma K [et al.] Modulation of the Gut Microbiota by Nutrition and Its Relationship to Epigenetics. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 2
• [współaut.] Ferenc K, Sokal-Dembowska A, Stasik K [et al.] Common Denominator of MASLD and Some Non-Communicable Diseases. - Current Issues in Molecular Biology, 2024, Vol. 46, iss. 7, p. 6690-6709
• [współaut.] Gruszecka J, Filip R The Diagnosis of Intestinal Fibrosis in Crohn's Disease - Present and Future. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 13
• [współaut.] Sheikh I, Bianchi-Smak J, Laubitz D [et al.] Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis. - Gut Microbes, 2024, Vol. 16, iss. 1
• [współaut.] Sokal-Dembowska A, Ferenc K, Filip R Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 10
• [współaut.] Sokal-Dembowska A, Ferenc K, Filip R Mechanisms of Insulin Signaling as a Potential Therapeutic Method in Intestinal Diseases. - Cells, 2024, Vol. 13, no. 22
• [współaut.] Sokal-Dembowska A, Filip R Flavonoids and Their Role in Preventing the Development and Progression of MAFLD by Modifying the Microbiota. - International Journal of Molecular Sciences, 2024, Vol. 25, iss. 20
• [współaut.] Ferenc K, Filip R Antioxidants as Protection against Reactive Oxidative Stress in Inflammatory Bowel Disease. - Metabolites, 2023, Vol. 13, iss. 4
• [współaut.] Ferenc K, Filip R Components of the Fiber Diet in the Prevention and Treatment of IBD - An Update. - Nutrients, 2023, Vol. 15, iss. 1
• [współaut.] Gruszecka J, Filip R What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature. - Metabolites, 2023, Vol. 13, iss. 3
• [współaut.] Michońska I, Polak-Szczybyło E, Sokal-Dembowska A [et al.] Nutritional Issues Faced by Patients with Intestinal Stoma : A Narrative Review. - Journal of Clinical Medicine, 2023, Vol. 12, no. 2
• [współaut.] Sokal-Dembowska A, Ferenc K, Motyka E [et al.] The Role of Genetic and Epigenetic Regulation in Intestinal Fibrosis in Inflammatory Bowel Disease : A Descending Process or A Programmed Consequence?. - Genes, 2023, Vol. 14, iss. 6
• [współaut.] Zielińska M, Helma K, Sokal-Dembowska A [et al.] Effect of Nigella sativa on Selected Gastrointestinal Diseases. - Current Issues in Molecular Biology, 2023, Vol. 45, iss. 4, p. 3016-3034
• [współaut.] Piątek D, Filip R The impact of selected food additives on the gastrointestinal tract in the example of nonspecific inflammatory bowel diseases. - Archives of Medical Science, 2022, Vol. 18, iss. 5, 11 s.
• [współaut.] Sokal-Dembowska A Starzenie się mózgu i ryzyko wystąpienia zespołu otępiennego - czy odpowiednia dieta może temu zapobiec?. - Medycyna Ogólna i Nauki o Zdrowiu, 2022, Vol. 28, nr 1, s. 20-27
• [współaut.] Sokal-Dembowska A, Pardak P, Filip R Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. - Canadian Journal of Gastroenterology and Hepatology, 2022, Vol. 2022, 13 s.
• [współaut.] Zielińska M, Sokal-Dembowska A, Filip R Genetic and Epigenetic Etiology of Inflammatory Bowel Disease : An Update. - Genes, 2022, Vol. 13, iss. 12
• [współaut.] Filip R, Piątek D, Sztembis J [et al.] The effect of treatment with TNF-A inhibitors on bone turnover and bone mineral density (BMD) in patients with inflammatory bowel diseases. - United European Gastroenterology Journal, 2021, Vol. 9, suppl. S8, s. 578
• [współaut.] Piątek D, Sztembis J, Korona-Głowniak I [et al.] Non-IBD changes in the Oral Musoca in Patients with Inflammatory Bowel Diseases : a Cross Sectional Study in Polish Patients. - United European Gastroenterology Journal, 2021, Vol. 96, suppl. S8, s. 432
• [współaut.] Sokal-Dembowska A, Tabarkiewicz J, Filip R Dietary Intake of Endocrine Disrupting Substances Presents in Environment and Their Impact on Thyroid Function. - Nutrients, 2021, Vol. 13, iss. 3
• [współaut.] Sokal-Dembowska A, Tabarkiewicz J, Filip R TiO2 - do we have to worry about it? : One of the important aetiological factors in inflammatory bowel disease. - Przegląd Gastroenterologiczny, 2021, Vol. 16, nr 2, s. 106-110
• [współaut.] Sokal-Dembowska A, Chmiel J, Michalec J Wpływ mikrobioty jelitowej na ośrodkowy układ nerwowy i występowanie zaburzeń psychicznych W: Różnorodność problemów klinicznych i badawczych w naukach o zdrowiu. T. 1 / pod redakcją Lidii Perenc. Rzeszów, Uniwersytet Rzeszowski: 2021, S. 60-72
• [współaut.] Łuszczki E, Sokal-Dembowska A, Bartosiewicz A [et al.] Resting energy expenditure of physically active boys in Southeastern Poland - the accuracy and validity of predictive equations. - Metabolites, 2020, Vol. 10, iss. 12, 17s.
• [współaut.] Filip R, Pękala A P437 Anti-TNF α antibodies in patients with inflammatory bowel disease naive to anti-TNF therapy treated with biosimilar infliximab (CT-P13) : a prospective single-centre real-life study. - Journal of Crohn's and Colitis, 2020, Vol. 14, suppl. 1, s. S396-S397
• [współaut.] Filip R, Piątek D, Sztembis J [et al.] P707 Anti-TNFα therapy has no effect on bone mineral density in younger patients with inflammatory bowel disease : A single-centre observational study. - Journal of Crohn's and Colitis, 2020, Vol. 14, suppl. 1, s. S572
• [współaut.] Pardak P, Pękala A, Filip R Gastro-esophageal reflux and obstructive sleep apnea - is there a link?. - European Journal of Clinical and Experimental Medicine, 2020, vol. 18, nr 2, s. 110-115
• [współaut.] Piątek D, Filip R The Influence of Nutrients on Inflammatory Bowel Diseases. - Journal of Nutrition and Metabolism, 2020, 2020, Article ID 2894169
• [współaut.] Piątek D, Korona-Głowniak I, Malm A [et al.] P790 Dental caries occurrence among patients with inflammatory bowel disease (IBD). - Journal of Crohn's and Colitis, 2020, Vol. 14, suppl. 1, s. S622-S623
• [współaut.] Sokal-Dembowska A, Filip R What Was First, Obesity or Inflammatory Bowel Disease? What Does the Gut Microbiota Have to Do with It?. - Nutrients, 2020, Vol. 12, iss. 10
• [współaut.] Sokal-Dembowska A Kalorymetria pośrednia w praktyce klinicznej - "złoty standard" w ocenie podstawowego wydatku energetycznego W: Współczesne kierunki badań w naukach o zdrowiu / pod redakcją Lidii Perenc. Rzeszów, Uniwersytet Rzeszowski: 2020, S. 41-55
• [współaut.] Polak-Szczybyło E, Łuszczki E, Motyka E [et al.] Zaburzenia karmienia jako problem multidyscyplinarny. - Standardy Medyczne. Pediatria, 2019, t. 16, nr 5, s. 631-636
• [współaut.] Sztembis J, Piątek D, Kiela P [et al.] P556 The prevalence of metabolic bone disease in patients with IBD- preliminary results from POLIBD study. - Journal of Crohn's and Colitis, 2019, Vol. 13, suppl. 1, S. S392
• [współaut.] Łuszczki E, Polak-Szczybyło E, Sobek G [et al.] Żywienie noworodków urodzonych przedwcześnie po wypisie ze szpitala. - Standardy Medyczne. Pediatria, 2018, Vol. 15, nr 2, s. 291-291
• [współaut.] Dereń K, Sokal-Dembowska A, Łuszczki E [et al.] Risk factors and the incidence of overweight and obesity in pre-school children from the southern part of Poland. - European Journal of Clinical and Experimental Medicine, 2018, T. 16, no. 2, s. 97-102
• [współaut.] Pękala A, Witas B, Filip R Efficacy and Safety of Biosymilar Infliximab Ct-P13 in Patients with Crohn's Disease Who Were NaïVe to anti-Tnf Therapy : Preliminary Results from Polibd Study. - United European Gastroenterology Journal, 2018, Vol. 6, suppl. S8, s. A659
• [współaut.] Piątek D, Kiela P, Sztembis J [et al.] Selected cytokines in periodontitis in patients with Crohn's Disease - preliminary results from polibd study. - United European Gastroenterology Journal, 2018, Vol. 6, suppl. S8, s. A635
• [współaut.] Piątek D, Korona-Głowniak I, Sztembis J [et al.] The impact of Crohn's disease on periodontal status-preliminary results from polibd study. - United European Gastroenterology Journal, 2018, Vol. 6, suppl. S8, s. A634
• [współaut.] Sokal-Dembowska A, Łuszczki E, Polak-Szczybyło E [et al.] Wprowadzanie pokarmów uzupełniających do diety niemowlęcia. - Standardy Medyczne. Pediatria, 2018, Vol. 15, nr 3, s. 425-431
• [współaut.] Sztembis J, Filip R, Pękala A [et al.] P834 Metabolic syndrome occurrence in patients with inflammatory bowel disease in Poland - preliminary results from the POLIBD study. - Journal of Crohn's and Colitis, 2018, Vol. 12, suppl. 1, S. S538
• [współaut.] Dereń K, Łuszczki E, Buczkowicz P [et al.] Nutritional behavior and the use of oral contraception in women of childbearing age W: The faces of contemporary pediatrics : from clinical problems to public health : International Paediatric Conference: Rzeszów, Poland: 24-26 May 2018: abstract book. Rzeszów, Uniwersytet Rzeszowski: 2018, S. 28
• [współaut.] Dereń K, Łuszczki E, Warchoł P [et al.] Nutritional behavior of women with polycystic ovary syndrome W: The faces of contemporary pediatrics : from clinical problems to public health : International Paediatric Conference: Rzeszów, Poland: 24-26 May 2018: abstract book. Rzeszów, Uniwersytet Rzeszowski: 2018, S. 29
• [współaut.] Korona-Głowniak I, Piątek D, Siwiec J [et al.] Prevalence, quantification of Streptococcus mutans and distribution its serotypes in patients with inflammatory bowel disease preliminary study from polibd study W: 2-nd International Conference on Pharmaceutical and Medical Sciences, Poprad, 21-23 September 2018 Slovakia : Abstracts / Faculty of Pharmacy, Jagiellonian University Medical College. Poprad, [b.w.]: 2018, S. 87-88
• [współaut.] Dereń K, Gaweł M, Łuszczki E [et al.] Nutritional behavior of pregnant women from the Podkarpacie province. - European Journal of Clinical and Experimental Medicine, 2017, vol. 15, nr 4, s. 322-329
• [współaut.] Piątek D, Filip R Macro and micronutrient deficiency in inflammatory bowel diseases. - European Journal of Clinical and Experimental Medicine, 2017, vol. 15, nr 4, s. 342-348
• [współaut.] Piątek D, Korona-Głowniak I, Malm A [et al.] The impact of inflammatory bowel disease on hard teeth tissues - preliminary results from POLIBD study. - United European Gastroenterology Journal, 2017, Vol. 1, suppl. 1, s. 724
• [współaut.] Pierzynowska K, Pierzynowski S, Lozinska L [et al.] The influence of oxalate decarboxylase on the urinary oxalate excretion in swine model of nephrocalcinosis induced by hydroxyproline. - European Journal of Clinical and Experimental Medicine, 2017, vol. 15, nr 3, s. 206-216